Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.

Publisher: Current Science Country of Publication: United States NLM ID: 101093791 Publication Model: Electronic Cited Medium: Internet ISSN: 1539-0829 (Electronic) Linking ISSN: 15344827 NLM ISO Abbreviation: Curr Diab Rep Subsets: MEDLINE

Original Publication: Philadelphia, PA : Current Science, c2001-

Mass Screening*; Diabetes Mellitus, Type 2/*diagnosis ; Diabetes Mellitus, Type 2/*prevention & control; Adult ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/therapy ; Humans ; Life Style ; Risk Assessment ; United States

Purpose of Review: Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice, while highlighting opportunities to improve diabetes screening and prevention efforts population-wide.
Recent Findings: Awareness of diabetes risk is low, and many adults with prediabetes are not identified through existing screening efforts. Accumulating evidence and policies support expansion of the Diabetes Prevention Program (DPP) into clinical and community settings. However, the infrastructure to facilitate referrals and promote data exchange among patients, clinical settings, and community-based DPP programs is lacking. Development of evidence-driven, scalable processes for assessing diabetes risk, screening eligible adults, and delivering preventive treatments are needed to effectively improve the glycemic health of the US adult population.

Arch Intern Med. 2007 May 28;167(10):1068-74. (PMID: 17533210)
BMJ Open. 2017 Dec 27;7(12):e017725. (PMID: 29284715)
J Gen Intern Med. 2018 Feb;33(2):142-144. (PMID: 29134572)
J Gen Intern Med. 2018 Jul;33(7):1100-1108. (PMID: 29651678)
Ann Intern Med. 2009 Jun 2;150(11):741-51. (PMID: 19487709)
J Clin Endocrinol Metab. 2015 Apr;100(4):1503-10. (PMID: 25650899)
Diabetes Care. 1997 Apr;20(4):537-44. (PMID: 9096977)
BMC Med. 2011 Sep 08;9:103. (PMID: 21902820)
J Public Health Dent. 2015 Summer;75(3):175-82. (PMID: 25662777)
Ann Fam Med. 2017 Mar;15(2):162-164. (PMID: 28289117)
MMWR Morb Mortal Wkly Rep. 2013 Mar 22;62(11):209-12. (PMID: 23515058)
Am J Prev Med. 2017 Jul;53(1):70-77. (PMID: 28094135)
J Am Geriatr Soc. 2015 Jun;63(6):1067-74. (PMID: 26031428)
Diabetologia. 2011 Feb;54(2):300-7. (PMID: 21046360)
Ann Fam Med. 2007 Sep-Oct;5(5):425-9. (PMID: 17893384)
JAMA. 2015 Sep 8;314(10):1021-9. (PMID: 26348752)
BMJ. 2011 Nov 28;343:d7163. (PMID: 22123912)
Am J Public Health. 2016 May;106(5):949-56. (PMID: 26890171)
PLoS One. 2015 Apr 30;10(4):e0125249. (PMID: 25928306)
Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80. (PMID: 24731674)
Am J Epidemiol. 2010 May 1;171(9):980-8. (PMID: 20375194)
Diabetes Care. 2017 Jul;40(7):887-893. (PMID: 28373205)
Ann Intern Med. 2009 Dec 1;151(11):775-83. (PMID: 19949143)
Diabetes Care. 2005 Aug;28(8):2013-8. (PMID: 16043747)
Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. (PMID: 17601626)
Ann Intern Med. 2018 Aug 7;169(3):156-164. (PMID: 29913486)
Ann Intern Med. 2015 Dec 1;163(11):861-8. (PMID: 26501513)
PLoS One. 2016 Oct 5;11(10):e0163627. (PMID: 27706216)
Curr Diab Rep. 2016 Jun;16(6):55. (PMID: 27145778)
Lancet. 2009 Nov 14;374(9702):1677-86. (PMID: 19878986)
Diabetologia. 2006 Feb;49(2):289-97. (PMID: 16391903)
Diabetes Res Clin Pract. 2014 Dec;106(3):e74-8. (PMID: 25451907)
JAMA Intern Med. 2017 Dec 1;177(12):1808-1817. (PMID: 29114778)
Ann Intern Med. 2015 Apr 21;162(8):542-8. (PMID: 25894024)
PLoS Med. 2016 Jul 12;13(7):e1002074. (PMID: 27403739)
PLoS Med. 2016 Jul 26;13(7):e1002095. (PMID: 27459705)
Biomed Res Int. 2013;2013:191209. (PMID: 24369008)
Am J Prev Med. 2017 Jun;52(6):710-716. (PMID: 28279547)
Clin Chem. 2014 Aug;60(8):1062-72. (PMID: 24865164)
Ann Intern Med. 2015 Feb 3;162(3):192-204. (PMID: 25531400)
Ann Intern Med. 2014 Oct 21;161(8):587-93. (PMID: 25155419)
Clin Chem Lab Med. 2017 Feb 1;55(2):167-180. (PMID: 27658148)
Health Aff (Millwood). 2012 Jan;31(1):67-75. (PMID: 22232096)
Diabetes Care. 2017 Oct;40(10):1331-1341. (PMID: 28500215)
Am J Prev Med. 2013 Apr;44(4 Suppl 4):S301-6. (PMID: 23498291)
N Engl J Med. 2001 May 3;344(18):1343-50. (PMID: 11333990)
J Med Screen. 1994 Oct;1(4):208. (PMID: 8790520)
N Engl J Med. 2014 Apr 17;370(16):1514-23. (PMID: 24738668)
Transl Behav Med. 2017 Jun;7(2):286-291. (PMID: 28417426)
Health Serv Res Manag Epidemiol. 2017 Aug 29;4:2333392817721647. (PMID: 28890909)
Ann Intern Med. 2005 Mar 1;142(5):323-32. (PMID: 15738451)
Diabetes Care. 2007 Mar;30(3):753-9. (PMID: 17327355)
Diabetes Care. 2014 Apr;37(4):922-33. (PMID: 24652723)
Diabetes Care. 2010 Dec;33(12):2543-5. (PMID: 20805260)
Curr Diab Rep. 2017 Feb;17(2):9. (PMID: 28150162)
Diabetes Care. 2004 Jan;27(1):9-12. (PMID: 14693958)
Endocr Pract. 2015 Apr;21 Suppl 1:1-87. (PMID: 25869408)
N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
Am J Prev Med. 2018 Aug;55(2):e39-e47. (PMID: 29934016)
Lancet. 2008 May 24;371(9626):1783-9. (PMID: 18502303)
Diabetes Care. 1999 Apr;22(4):623-34. (PMID: 10189543)
Curr Diab Rep. 2017 May;17(5):31. (PMID: 28364355)
N Engl J Med. 2008 Oct 9;359(15):1577-89. (PMID: 18784090)
Am J Prev Med. 2013 Apr;44(4 Suppl 4):S346-51. (PMID: 23498297)
Lancet. 2012 Nov 17;380(9855):1741-8. (PMID: 23040422)
Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. (PMID: 26377054)
Diabetes Educ. 2014 Jul;40(4):435-443. (PMID: 24723130)

K23 DK104065 United States DK NIDDK NIH HHS; R21 DK112066 United States DK NIDDK NIH HHS

Keywords: Diabetes prevention; Diabetes risk assessment; Diabetes screening; Population health

Date Created: 20180920 Date Completed: 20190916 Latest Revision: 20200112

20240628

PMC6953473

10.1007/s11892-018-1090-5

30229480